cytarabine has been researched along with pyrimidinones in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, EG; Fast, PE; Franz, CL; Hatfield, CA; Licht, NJ; Merritt, MV | 1 |
| Bartlett, MG; Chu, CK; Kotra, LP; Wang, PP | 1 |
| Buck, SA; Caldwell, JT; Edwards, H; Ge, Y; Taub, JW | 1 |
| Baturin, D; Burleson, TM; Ford, JB; Kim, YM; Porter, CC; Van Linden, AA | 1 |
| Fosmire, SP; Garcia, TB; Porter, CC | 1 |
| Aleem, E; Arceci, RJ; Azorsa, DO; Bista, R; Henry, MM; Lee, DW; Patel, AR; Wai, DH | 1 |
| Hu, BF; Shen, SH; Wang, GL; Wang, J | 1 |
7 other study(ies) available for cytarabine and pyrimidinones
| Article | Year |
|---|---|
Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levels.
Topics: Animals; Antibody Formation; Corticosterone; Cyclophosphamide; Cytarabine; Female; Fluorescent Antibody Technique; Graft vs Host Reaction; Hydrocortisone; Immunosuppressive Agents; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Pyrimidinones; Spleen; Thymus Gland | 1982 |
Structure determination of 4-azido-2-pyrimidinone nucleoside analogs using mass spectrometry.
Topics: Antineoplastic Agents; Azides; Cytarabine; Mass Spectrometry; Molecular Structure; Prodrugs; Pyrimidine Nucleosides; Pyrimidinones | 1999 |
Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; Cytarabine; Down Syndrome; Drug Synergism; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Nuclear Proteins; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Reverse Transcriptase Polymerase Chain Reaction | 2014 |
AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cytarabine; DNA Repair; Drug Synergism; Female; Flow Cytometry; Humans; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Pyrimidinones; Xenograft Model Antitumor Assays | 2015 |
Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cytarabine; DNA Damage; Drug Resistance, Neoplasm; Humans; Nuclear Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones | 2018 |
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.
Topics: Adolescent; Adrenal Cortex Hormones; Butadienes; Combined Modality Therapy; Cytarabine; Disease Progression; Drug Resistance; Drug Therapy, Combination; Enzyme Activation; Exons; HEK293 Cells; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Molecular Targeted Therapy; Mutation; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyridones; Pyrimidinones; Recombinant Fusion Proteins; Sequence Deletion; Thiophenes; Vincristine | 2018 |
Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Child; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Dasatinib; Humans; Maintenance Chemotherapy; Male; Pancreatitis; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridones; Pyrimidinones; Treatment Outcome | 2021 |